Aegon sells remaining US life reinsurance business to SCOR

Dutch insurance group Aegon has agreed to divest the last substantial block of its life reinsurance business to SCOR Global Life.

The transaction is a part of Aegon’s strategic objective to reduce the amount of capital allocated to its run-off businesses.

Under the agreement, Aegon’s Transamerica life subsidiaries will reinsure approximately $700 million of liabilities through SCOR Global Life. The transaction covers the last substantial block of life reinsurance business that Transamerica retained after it divested the vast majority of its reinsurance business to SCOR Global Life in 2011 and 2017.

Aegon expects the transaction to provide a one-time benefit of approximately $50 million on Transamerica’s capital position and a slightly positive effect on recurring capital generation.

The insurer said the future underlying earnings are not affected by this transaction as earnings of this block of reinsurance business are part of run-off businesses, which are not included in underlying earnings before tax. The transaction is expected to result in a pre-tax IFRS loss of approximately $105 million and will be reported in other charges in the second half 2018 results.

As a result of the transaction, Aegon said it will significantly reduce the size of a related captive insurance company and the related letter of credit facility in place to finance redundant reserves, generally referred to as XXX term life insurance reserves.

Get all the latest re/insurance industry news with our daily newsletter -  sign up here.

More of today's news

Munich Re shrinks reinsurance business in Q2

Aspen elevates CUO to lead reinsurance as CEO Lillelund resigns

Travelers replaces CFO as Benet steps down from top position

S&P warns on Swiss Re ReAssure ratings as parent ponders IPO

Zurich reveals new Canada CEO, chief agent

Munich Re grows 42% at July renewals

Revenues up at White Mountains but profits dip

Hastings Group overcomes hurdles to post strong H1 results

Don't miss our insurtech email newsletter - sign up today